Renal Carcinoma
Conditions
Interventions
Experimental Group:none
Sponsors
Xiangya Hospital of Central South University
Eligibility
Sex/Gender
Male
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1. When signing the informed consent form, the age is equal to or greater than 18 years old and less than 90 years old. 2. Patients diagnosed with renal cell carcinoma through puncture/surgical pathology. 3. The expected survival period is>12 months. 4. The ECOG score is 0-2 points. 5. The patient agrees and has the ability to follow the planned research visit, provide surgical samples, and cooperate with other research steps. 6. The patient has normal organ function, with WBC = 3000/mm3 or absolute neutrophil count = 1500/mm3, and AST and ALT below 1.5 ULN.
Exclusion criteria
Exclusion criteria: 1. Researchers have determined that patients may have other serious diseases that may affect follow-up and short-term survival, and any medical reasons that indicate a significant risk of death during the one-year study period. 2. Those who have had any other malignant tumors within the past 3 years prior to enrollment. 3. Unable to obtain clinical information required for the study. 4. Other researchers believe that it is not suitable for enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transcriptome sequencing; | — |
Secondary
| Measure | Time frame |
|---|---|
| clinical stage;pathological stage; | — |
Countries
China
Contacts
Public ContactLin Qi
Xiangya Hospital of Central South University
Outcome results
None listed